Related references
Note: Only part of the references are listed.A phase II trial of intraperitoneal interleukin-2 in patients with platinum-resistant or platinum-refractory ovarian cancer
Anda M. Vlad et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
New Therapies for Castration-Resistant Prostate Cancer.
Dan L. Longo
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Omental immune aggregates and tumor metastasis within the peritoneal cavity
Elizabeth W. Sorensen et al.
IMMUNOLOGIC RESEARCH (2009)
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Suzanne Ostrand-Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Local therapy of cancer with free IL-2
Willem Den Otter et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Regulatory T cells and treatment of cancer
Tyler J. Curiel
CURRENT OPINION IN IMMUNOLOGY (2008)
Management of Prostate Cancer
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Molecular origins of cancer - Cancer immunology
Olivera J. Finn
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Steven A. Rosenberg et al.
NATURE REVIEWS CANCER (2008)
Interleukin 2: from immunostimulation to immunoregulation and back again
Martin F. Bachmann et al.
EMBO REPORTS (2007)
Synergistic effect of intratumoral IL-12 and TNF-α microspheres:: systemic anti-tumor immunity is mediated by both CD8+ CTL and NK cells
Michael S. Sabel et al.
SURGERY (2007)
Unique human tumor antigens: Immunobiology and use in clinical trials
Giorgio Parmiani et al.
JOURNAL OF IMMUNOLOGY (2007)
Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth
Scott A. Gerber et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Insufficient ability of omental milky spots to prevent peritoneal tumor outgrowth supports omentectomy in minimal residual disease
S. J. Oosterling et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Heterologous expression of proteins from Plasmodium falciparum:: Results from 1000 genes
Christopher Mehlin et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2006)
Antibody targeted drugs as cancer therapeutics
D Schrama et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Modification of MTT assay conditions to examine the cytotoxic effects of amitraz on the human lymphoblastoid cell line, WIL2NS
FM Young et al.
TOXICOLOGY IN VITRO (2005)
High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma
J Nikkola et al.
CLINICAL CANCER RESEARCH (2005)
Phase I study of the intratumoral administration of recombinant canarypox viruses expressing B7.1 and interleukin 12 in patients with metastatic melanoma
PL Triozzi et al.
CLINICAL CANCER RESEARCH (2005)
Immunosuppressive networks in the tumour environment and their therapeutic relevance
WP Zou
NATURE REVIEWS CANCER (2005)
Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors
B Sangro et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Antibody-cytokine fusion proteins: innovative weapons in the war against cancer
JS Dela Cruz et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2004)
Optimization of codon pair use within the (GGGGS)(3) linker sequence results in enhanced protein expression
R Trinh et al.
MOLECULAR IMMUNOLOGY (2004)
Progress on new vaccine strategies for the immunotherapy and prevention of cancer
JA Berzofsky et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Targeting cytokines to inflammation sites
G Adams et al.
NATURE BIOTECHNOLOGY (2003)
Interleukin-12 and the regulation of innate resistance and adaptive immunity
G Trinchieri
NATURE REVIEWS IMMUNOLOGY (2003)
Biology of prostate-specific antigen
SP Balk et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors
TL Fisher et al.
PROSTATE (2002)
A unique substrate recognition profile for matrix metalloproteinase-2
EI Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
Recombinant human antibody single chain variable fragments reactive with Candida albicans surface antigens
CG Haidaris et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
T-cell antigen discovery (T-CAD) assay: a novel technique for identifying T cell epitopes
MJ Turner et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Controlled local delivery of interleukin-2 by biodegradable polymers protects animals from experimental brain tumors and liver tumors
J Hanes et al.
PHARMACEUTICAL RESEARCH (2001)
In vivo molecular target assessment of matrix metalloproteinase inhibition
C Bremer et al.
NATURE MEDICINE (2001)
Progress in human tumour immunology and immunotherapy
SA Rosenberg
NATURE (2001)
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
G Bergers et al.
NATURE CELL BIOLOGY (2000)
Matrix metalloproteinases in human melanoma
UB Hofmann et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2000)
Share Paper
